IGF1 and hereditary endocrine growth disease: Unfortunately, the use of IGF-I as a diagnostic tool for growth disorders is complicated by inter-assay variability that may arise from differences in antibody specificity, pre-analytical sample preparation strategies to remove binding protein interferences, non-commutability of calibration material, and dynamic range of the detection methodology [1]–[3].